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Summary
Serotonin (5-HT) and leptin play important roles in the modulation of energy balance. Here we
investigated mechanisms by which leptin might interact with CNS 5-HT pathways to influence
appetite. Although some leptin receptor (LepRb) neurons lie close to 5-HT neurons in the dorsal
raphe (DR), 5-HT neurons do not express LepRb. Indeed, while leptin hyperpolarizes some non-5-
HT DR neurons, leptin does not alter the activity of DR 5-HT neurons. Furthermore, 5-HT
depletion does not impair the anorectic effects of leptin. The serotonin transporter-cre allele
(Sertcre) is expressed in 5-HT (and developmentally in some non-5-HT) neurons. While Sertcre
promotes LepRb excision in a few LepRb neurons in the hypothalamus, it is not active in DR
LepRb neurons, and neuron-specific Sertcre-mediated LepRb inactivation in mice does not alter
body weight or adiposity. Thus, leptin does not directly influence 5-HT neurons and does not
meaningfully modulate important appetite-related determinants via 5-HT neuron function.
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Introduction
Leptin, a hormone secreted by adipocytes in proportion to fat mass, acts via the long form of
the leptin receptor (LepRb) to regulate energy homeostasis (Myers et al., 2009). Neuronal
specific deletion of LepR promotes hyperphagia and obesity (Cohen et al., 2001), and
restoration of neuronal LepRb in LepR-deficient mice normalizes food intake and body
weight (de Luca et al., 2005), indicating that leptin’s effects on energy balance are achieved
via brain LepRb.
Within the brain, multiple populations of LepRb-expressing neurons that contribute to
energy homeostasis have been identified, including (i) neurons of the hypothalamic arcuate
nucleus (ARC) that express pro-opiomelanocortin (POMC) or agouti-related peptide (AgRP)
(Balthasar et al., 2004; van de Wall et al., 2008), (ii) SF1-expressing neurons of the
ventromedial nucleus of the hypothalamus (Dhillon et al., 2006), (iii) dopaminergic neurons
in the ventral tegmental area (Fulton et al., 2006; Hommel et al., 2006), (iv) GABAergic
neurons of the lateral hypothalamic area (LHA) (Leinninger et al., 2009), and (v) neurons
within the nucleus of the solitary tract (Hayes et al., 2009), among others (Myers et al.,
2009; Patterson et al., 2011; Scott et al., 2009).
Leptin also acts in concert with the brain serotonin (5-HT) pathways, although important
discrepancies exist regarding the mechanisms underlying this interaction. A variety of data
suggest that leptin and 5-HT function independently, but converge in the ARC, although
recent publications report a role for direct leptin action via brain 5-HT neurons (Calapai et
al., 1999; Harris et al., 1998; von Meyenburg et al., 2003; Yadav et al., 2009; Yadav et al.,
2011; Yamada et al., 2003). We thus generated and utilized several novel mouse lines to
resolve these issues and clarify the potential role for 5-HT neurons in leptin action.
Results and Discussion
Distinct localization of LepRb and 5-HT in CNS
Analysis using a LepRb riboprobe (Elmquist et al., 1998) revealed that, with the exception
of the dorsal raphe nucleus (DR), brain regions containing 5-HT do not express Leprb
mRNA in the rat (Figure S1A–F’) or mouse (Figure S1G–L’). Similarly, utilizing
LepRbEGFP mice (Patterson et al., 2011), we observed no co-localization of LepRb with 5-
HT in the DR (Figures 1A, 1A’, and S1). In contrast, most DR neurons containing calbindin
(Calb), a marker of interneurons, expressed LepRb (Figures 1B and 1B’); and, as previously
reported, a small population of DR dopamine (DA) neurons also expressed LepRb (Figure
S1M and S1M’) (Scott et al., 2009).
We also assayed leptin-induced STAT3 phosphorylation (pSTAT3), which is directly
mediated by activated LepRb, to examine direct leptin action in the midbrain. Leptin-
induced pSTAT3 was absent from all 5-HT containing sites, with the exception of the DR,
in the rat (Figure S1P–V’) and mouse (Figure S1W-AC’). Within the DR, leptin-induced
pSTAT3 was absent from all 5-HT neurons in the rat (Figures 1C, 1C’, and S1P–V’) and
mouse (Figures 1D, 1D’, and S1W-AC’). In contrast, most DR Calb neurons in the rat
(Figures 1E and 1E’) and mouse (Figures 1F and 1F’) contained leptin-induced pSTAT3, as
did a subpopulation of DR DA neurons in the rat (Figure S1N and S1N’) and mouse (Figure
S1O and S1O’). Thus, although some Calb- and DA-expressing DR neurons contain
functional LepRb, CNS 5-HT neurons do not.
Leptin does not alter the activity of DR 5-HT neurons
We also examined the ability of leptin to influence the membrane potential of identified DR
5-HT neurons in acute slice preparations from wild-type mice. We recorded from 26 DR
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neurons in current-clamp mode, after which recorded cells were filled with biocytin and
slices were subjected to the post hoc IHC identification of 5-HT. None (0/5) of the recorded
5-HT-containing neurons demonstrated detectable changes in membrane potential in
response to leptin (Figure 2A–C). Consistent with previous results from DR neurons not
characterized post hoc by IHC (Yadav, et al, 2009), leptin inhibited the firing of a
subpopulation (29% (6/21)) of DR neurons (Figure 2D–F, p<0.01). None of these leptin-
responsive cells were 5-HT positive (Figure 2F).
Yadav, et al., reported increased expression of DR tryptophan hydroxylase 2 (Tph2), which
mediates 5-HT synthesis, in old, but not young, Lepob/ob mice (Yadav et al., 2009), which
suggests that Tph2 expression changes in Lepob/ob mice are related to age, rather than to
direct leptin effects. Indeed, unlike Yadav, et al (2009), we were not able to detect an effect
of leptin on DR Tph2 in wild-type mice, either by acute peripheral (0.5, 2.0, or 5.0 mg/kg,
IP) or central (5 µg ICV) leptin treatment (Figure S2A, S2B). Similarly, we were unable to
detect any changes in DR Tph2 in fasted rats receiving continuous leptin treatment (a
paradigm in which leptin induces changes in other appetite-associated neuropeptides (Ahima
et al., 1999)) (Figure S2C). Our data suggest that leptin does not directly or significantly
modulate DR Tph2 expression.
Leptin-induced hypophagia is independent of serotonin bioavailability
While leptin does not directly control CNS 5-HT neurons, we investigated potential indirect
interactions between 5-HT and LepRb-expressing cells using a transgenic mouse line in
which LepRb neurons throughout the brain express the transneuronal tracer wheat germ
agglutinin (Figure S3). Our observations indicate that an unidentified population of LepRb
neurons lie in synaptic contact with DR 5-HT neurons (Figure S3).
In order to address the possibility of 5-HT participation in leptin action via such an indirect
mechanism, we utilized PCPA to selectively deplete brain 5-HT, and by consequence its
metabolite 5-hydroxyindoleacetic acid, by ~80% (Figure 3A). Noradrenaline (NA) and DA
were not affected (Figure 3B–C). This profound depletion of 5-HT did not interfere with the
ability of leptin (5 mg/kg, i.p.) to attenuate food intake (Figure 3D). Thus, 5-HT is not
required for the anorectic action of leptin. These data are consistent with the notion that
leptin does not mediate its effects on appetite via LepRb neurons synapsing on 5-HT cells
and also with previous reports. Specifically, leptin exhibits normal anorectic efficacy in
mice null for 5-HT2CR (Nonogaki et al., 1998), and mice null for both leptin and 5-HT2CR
show greater hyperphagia than mice with either mutation alone (Wade et al., 2008).
Furthermore, 5-HT requires the melanocortin pathway to influence food intake, whereas
leptin affects appetite through both melanocortin-dependent and -independent pathways
(Balthasar et al., 2004; Dhillon et al., 2006; Heisler et al., 2002; Lam et al., 2008; Marsh et
al., 1999). Thus, leptin’s effects on appetite and body weight are unlikely to be substantially
5-HT-dependent.
Deletion of LepRb from Sert-cre neurons does not affect body weight
A recent paper by Yadav et al. reported that LepRb in 5-HT neurons is crucial for most
leptin action (Yadav et al., 2009). Clearly, this conclusion is incompatible with the lack of
LepRb/5-HT co-expression, the lack of direct leptin effect on DR 5-HT neurons, and the
irrelevance of brain 5-HT content to the anorexic action of leptin that we have demonstrated
here. Methodological factors may have promoted non-specific signal in the LepRb
localization studies performed by Yadav et al., as their depiction of LepRb abundance in the
median raphe (MnR) as well as the DR is not consistent with previous reports of LepRb
distribution (Elmquist et al., 1998; Patterson et al., 2011; Scott et al., 2009).
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Yadav et al. reported that mice lacking LepRb in 5-HT transporter-cre (Sertcre)-expressing
neurons are hyperphagic and obese (Yadav et al., 2009). Sert is broadly expressed in both 5-
HT and non-5-HT neurons during development (Lebrand et al., 1998;Narboux-Neme et al.,
2008). We therefore investigated the possibility that the Sertcre eliminated LepRb in crucial
populations of non-5-HT neurons (Figure 4). We crossed the Sertcre allele utilized by Yadav
et al. onto the conditional Leprfl background and the ROSA26-reporter alleles that express
EGFP/EYFP following cre-dependent excision (Mao et al., 1999; McMinn et al., 2005;
Narboux-Neme et al., 2008). Sertcre;ROSA26-reporter mice displayed Sertcre-mediated
recombination in non-5-HT neurons within the DR and elsewhere in the brain (Figure S4).
We examined the potential colocalization of Sertcre-induced EGFP with leptin-stimulated
pSTAT3 in Sertcre;ROSA26-EGFP mice (Figure 4A–C); this revealed no colocalization of
pSTAT3 with EGFP in the DR, although a few Sertcre/LepRb neurons were observed in the
LHA (Figure S4). Given the modest number of Sertcre/LepRb neurons revealed by this
analysis, we were surprised by the strong reported phenotype of Sertcre;Leprfl/fl (LeprSert)
mice (Yadav et al., 2009), and therefore bred Sertcre;Leprfl/+ animals to independently-
derived Leprfl/fl animals to generate LeprSert animals and littermate Leprfl/fl controls for
analysis. Examination of leptin-stimulated pSTAT3 in the DR of control (Figure 4D–F) and
LeprSert (Figure 4G–I) animals revealed similar levels and patterns of leptin-induced
pSTAT3-IR in LeprSert and control animals, consistent with the lack of Sertcre colocalization
with LepRb in the DR. We also examined the body weight and adiposity phenotypes of
LeprSert and littermate control animals (Figure 4J–L). Body and fat pad weights did not
differ between LeprSert and control animals, in contrast to the previously reported
approximately 60% increase in body weight and 3–4-fold increase in fat pad weight/body
weight at similar ages (Yadav et al., 2009). Vertebral bones from LeprSert mice were also
similar to controls (Figure 4M).
As the Leprfl allele is prone to germline excision in a number of cre strains (generating the
null LeprΔ allele) ((van de Wall et al., 2008) and our unpublished data), we thus examined
the possibility of such events in the LeprSert and littermate control animals from Figure 4
(Figure 4N). While LeprΔ is not distinguished from Leprfl by the standard 3-primer
multiplex genotyping paradigm to detect Leprfl and Lepr (Figure 4N, bottom panel)
(McMinn et al., 2005), separation of the primer sets into two reactions discerns Leprfl from
the germline deleted (LeprΔ) allele (Figure 4N, top and middle panels). Our analysis
revealed the presence of one germline-deleted LeprΔ allele in all of the LeprSert mice that we
examined (i.e., our LeprSert mice were uniformly Sertcre;Leprfl/Δ while controls were
Leprfl/fl), suggesting that germline deletion of Leprfl occurs uniformly in gametes containing
both Sertcre and Leprfl.
Given our present findings and the dramatic phenotype of the LeprSert mice (closely
resembling mice completely devoid of leptin action) reported by Yadav, et al., we surmise
that this tendency toward germline deletion combined with subsequent inbreeding yielded
LeprSert mice of the Sertcre;LeprΔ/Δ genotype (globally Lepr deficient) in their hands. While
the LeprSert animals studied by Yadav, et al. did not demonstrate overt diabetes as is often
observed in animals devoid of LepRb, genetic background effects can suppress
hyperglycemia in such animals, and this may have been the case in the mixed genetic
background animals studied (Moritani et al., 2006; Yadav et al., 2009). With regards to the
more recent study in which LepRb was deleted in adults by means of an inducible Tph2-cre
(for which no recombination mapping data were provided) (Yadav et al., 2011), we
postulate ectopic excision by this allele, given the substantial data demonstrating the lack of
LepRb expression in 5HT neurons and the failure of Sertcre-mediated LepRb deletion to
alter body energy balance.
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Neuron-specific LepRb deletion data have revealed no single pathway purported to mediate
the majority of appetitive leptin action, with the exception of the recently suggested 5-HT
system (Yadav et al., 2009; Yadav et al., 2011). Here we clarify that brain 5-HT neurons do
not express LepRb and do not, therefore, directly respond to leptin. Furthermore, our data
reveal that brain 5-HT is not required for the anorectic action of leptin, and that neuron-
specific excision of LepRb by Sertcre does not disrupt DR leptin action or the ability of
leptin to regulate energy homeostasis. We conclude that leptin does not substantially
influence energy balance via brain 5-HT neurons, and that the crucial population(s) of
LepRb neurons for the control of energy balance remain to be precisely identified.
EXPERIMENTAL PROCEDURES
Animals
LepRbEGFP mice were generated and propagated as previously described (Leinninger, et al.,
2009). For studies with wild type mice and rats, adult male pathogen-free C57BL/6 mice
(27–30 g) or Sprague-Dawley rats (250–300 g) were used (Taconic or Charles River). All
animals were individually housed with water and chow pellets available ad libitum (unless
otherwise stated) in a light- (12 hours on/12 hours off) and temperature-controlled (21.5°C
to 22.5°C) environment. Sertcre and Leprfl mice were the generous gifts of Xiaoxi Zhuang
(University of Chicago) and Streamson Chua (Albert Einstein College of Medicine),
respectively. ROSA26-EGFP and ROSA26-EYFP animals were from the Jackson
Laboratory. All procedures performed in the USA were in accordance with NIH guidelines
on animal care and use and with the approval of the UCUCA; those performed in the UK
were approved by the UK Home Office.
Sertcre mice were genotyped via qPCR, using primers and probes for Cre and Ngf, as
described (Leinninger et al., 2009). Leprfl was genotyped by conventional PCR
(mLepR-105, mLepR-65A for Leprfl and Lepr+) in addition to or in combination with
mLepR-105 and mLepR-106 for LeprΔ (McMinn et al., 2005).
Animal perfusion and Immunohistochemistry (IHC)
For pSTAT3 assessment in rats, femoral vein catheters were inserted as done previously
(Elias et al., 1998). Five days later, rats were injected with saline or recombinant rat leptin
(Sigma, 0.25 mg/kg or 1.0 mg/kg, i.v.) (n=4 per dose). For pSTAT3 assessment in C57BL/6
or Sertcre;reporter mice, saline or recombinant murine leptin (Peprotech or a generous gift of
Amylin Pharmaceuticals) were administered (n=3/genotype). Animals were deeply
anesthetized and perfused transcardially with 0.9% saline followed by 10% formalin
(Sigma); brain tissue was collected as previously described (Elias et al., 1998; Heisler et al.,
2002; Leinninger et al., 2009; Munzberg et al., 2007) (see Supplemental Methods for
details).
For dual-label IHC, primary antibodies for pSTAT3 (1:250, rabbit, Cell Signaling), GFP
(1:1,000, rabbit, Molecular Probes or 1:000, chicken, Abcam), 5-HT (1:1,000, goat,
Immunostar), Calb (1:500, mouse, Sigma), or TH (1:1,000, mouse, Chemicon) were
followed by secondary antibodies (Molecular Probes and Jackson Immunoresearch): FITC-
conjugated donkey anti-chicken (for GFP, 1:200), Alexa Fluor 594 conjugated to donkey
anti-goat (for 5-HT, 1:500), or Alexa Fluor 488 conjugated to donkey anti-mouse or anti-
rabbit (for Calb, TH, and GFP, 1:500).
Characterization of LeprSert mice
For the analysis of LeprSert and control mice, 8 wk-old male LeprSert (n=9) and control
littermate (n=5) mice were weighed. A subset of mice (LeprSert=5, control=4) were
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implanted with ICV cannulae as described (Leinninger et al., 2009). Coordinates to the
lateral ventricle were, relative to Bregma, A/P −0.34; M/L −1.0; and D/V −2.4. For
treatment, the dummy was replaced with an injector to deliver 3 µL of PBS or leptin (1 mg/
mL; Amylin Pharmaceuticals) at a rate of 1 µL per minute. Mice were perfused 1 hr after
treatment and brains were sectioned and analyzed for pSTAT3 and GFP as described above.
Mice that were not cannulated were also perfused at 9 wks of age. Gonadal fat was dissected
and weighed post-perfusion. Analysis of vertebral bones was carried out as described in the
supplemental methods.
5-HT depletion and leptin-induced hypophagia
Tryptophan hydroxylase inhibitor p-chlorophenylalanine (PCPA) treatment was done as
previously described (O'Leary et al., 2007). Briefly, mice were treated with 200 mg/kg i.p.
PCPA methyl ester hydrochloride (Sigma) or water twice daily (at 9:00 am and 4:00 pm) for
three days (n=44). Mice and food were weighed daily to ensure no adverse effect on body
weight or appetite. On the fourth day, mice received mouse recombinant leptin (Merck, 5
mg/kg, i.p.) or vehicle 120 min and 30 min prior to the onset of the dark cycle (lights off at
7:00 pm) and food was removed. At the onset of the dark cycle, food was returned and
subsequent 90 min intake was assessed. On completion of the study, animals were sacrificed
(n=11 per group) and brains rapidly removed and frozen. Brains were sectioned coronally at
150 µm on a cryostat and mounted onto glass slides. Micro-punches were taken from the
hypothalamus and striatum and homogenized in 60 µl of 0.2M perchloric acid by an
ultrasonic cell disruptor. Levels of 5-HT, 5-HIAA, DA and NA in the supernatant were
determined by HPLC and electrochemical detection, as described previously (Dalley et al.,
2002).
Electrophysiology
Acute coronal brain slices (250 µm thick) containing the DR were prepared from 22–44 day
old mice and standard whole-cell patch-clamp recordings were performed (Burdakov and
Ashcroft, 2002); see Supplemental Methods. As in previous studies (Yadav et al., 2009), to
facilitate the firing of serotonin neurons, we supplemented aCSF (see Supplemental
Methods for details) with phenylephrine (3 µM, Tocris). The following synaptic blockers
were also added to aCSF: AP5 (50 µM), CNQX (10 µM), picrotoxin (50 µM), strychnine (3
µM), and CGP52432 (10 µM) (Tocris). Data collection and analysis was performed using
Pulse (HEKA). To visualize neurons after recordings, biocytin (0.5 mg/ml, Tocris) was
added to the pipette solution (see Supplemental Methods for details), and the slices were
fixed in 10% formalin. Immunohistochemical processing for the detection of 5-HT was
performed as detailed above and images were acquired using an Olympus BX61WI confocal
microscope.
Data Analysis
The effect of drug treatment on cell firing rate was assessed using t-test. The effects of
PCPA on 5-HT, 5-HIAA, DA and NA levels in the striatum and hypothalamus were
analyzed with t-test. The effect of PCPA pretreatment and leptin treatment on food intake
was assessed with a two-way ANOVA, followed by Tukey HSD post hoc test. The effect of
genotype on body weight, gonadal fat, and bone density were analyzed with t-test. For all
analyses, significance was assigned at the p ≤ 0.05 level.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Brain LepRb neurons do not contain 5-HT and leptin treatment does not induce
LepRb signaling (pSTAT3) in 5-HT neurons
(A) LepRb (green), as detected by GFP-IR, was not colocalized with 5-HT (red) in the DR
of LepRbEGFP mice. In contrast, DR LepRb neurons (green) also expressed Calb-IR (red in
(B)) in LepRbEGFP mice. Accordingly, leptin-induced pSTAT3 (green) was not detected in
DR 5-HT neurons (red) in rats (C) treated with 1 mg/kg leptin i.v., or wild-type mice (D)
treated with 3 mg/kg leptin i.p. Leptin-induced pSTAT3 was present in calbindin neurons
(red) in rats (E) and wild-type mice (F). (A’–F’) are magnifications of the boxed areas in
(A–F) respectively. Scale bar in (F) = 200 µm also applies to (A–E). Scale bar in (F’) = 50
µm also applies to (A’–E’). Arrowheads indicate dual-labeled cells. See also Figure S1.
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Figure 2. Leptin does not alter the electrical activity of DR 5-HT neurons
(A) Representative firing trace of DR 5-HT cell in response to 500nM leptin. Expanded
traces highlight the firing rate before, during and after application. (B) Average firing rate of
DR 5-HT cells before and after 500 nM leptin treatment; 100% (n=5) of identified DR 5-HT
neurons are unaffected by 500 nM leptin (mean ± SEM). (C) Immunofluorescence imaging
of the cell shown in A, identified by biocytin staining (red); the cell contains 5-HT (green),
overlay is shown in yellow. (D) Representative firing trace of DR non-5-HT cell
demonstrating an inhibitory response to 500 nM leptin. Expanded traces highlight the firing
rate before, during and after application. (E) Non-5-HT DR neurons inhibited by leptin,
showing average firing rate before and after 500 nM leptin treatment (n=6; mean ± SEM,
**p<0.01). (F) Immunofluorescence imaging of the cell shown in (D), identified by biocytin
staining (red); the cell does not contain 5-HT (green). Scale bar in (C) and (F) = 30 µm. See
also Figure S2.
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Figure 3. Leptin-induced hypophagia is independent of serotonin bioavailability
Pre-treatment with the tryptophan hydroxylase inhibitor PCPA (200 mg/kg i.p. twice daily
for three days) (A) significantly depleted 5-HT (mean ± SEM), but did not influence (B) DA
(mean ± SEM) or (C) NA (mean ± SEM) in the brain (striatum (Str) and hypothalamus
(Hypo) presented). Levels of neurotransmitters were measured by HPLC. (D) This
substantial 5-HT depletion did not impair leptin’s effects on 90 min dark cycle food intake
(n=11 per treatment group, mean ± SEM). *p<0.05; **p<0.01, ***p<0.001. See also Figure
S3.
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Figure 4. Characterization of Sertcre/LepRb interaction
(A–C) Immunofluorescent analysis of leptin-stimulated pSTAT3 (red) and Sertcre (GFP,
green) in DR sections from Sertcre;ROSA26-EGFP mice. (D–I) Immunohistochemical
detection of ICV leptin-induced pSTAT3 in DR sections of control (D–F) and LeprSert mice
(G–I). (J–M) Body weight (8 weeks of age, J, mean ± SEM), gonadal fat pad weight (9
weeks of age, K, mean ± SEM), gonadal fat pad weight as a percentage of body weight (L,
mean ± SEM) and vertebral trabecular bone density (9 weeks of age, M, mean ± SEM) from
male control (black bars) and LeprSert (hashed bars) mice. (N) Genotyping of Lepr in three
representative control (Leprfl/fl) and LeprSert mice compared to animals of known genotypes.
Top panel, Lepr+ and Leprfl bands; middle panel, LeprΔ; lower panel, multiplex analysis
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fails to distinguish Leprfl from LeprΔ. Scalebars in (C,F,I) = 100 µm. Insets are digital
enlargements. See also Figure S4.
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